Randomized Controlled Trial on Visual Field Training

August 16, 2012 updated by: Eugenio A. Maul, Oftalmologia Hospital Sotero del Rio

Effect of Exposure to Computer Simulated Visual Field Testing on Variability and Reliability of Test Results: A Randomized Controlled Trial

Unreliability and visual field variability is a known problem with automated perimetry in both developing and developed country settings. This study will look at the effects of a computer program that allows new patients to practice the visual field exam before taking the actual exam. Our hypothesis is that the intervention group will have less variability as measured by mean deviation between exams and greater reliability as measured by the standard unreliability indexes of false positive rate, false negative rate, and fixation losses.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

3 study visits. Visit 1: Baseline visit for consent, getting baseline data and finally randomizing the patient. Those randomized to intervention get their first session of simulated visual field (2 per eye) on a regular computer for training purposes.

Visit 2: 1 to 2 days after baseline. The intervention group gets 1 practice test per eye. Then both groups get a regular automated visual field Visit 3: 1 to 2 weeks after baseline. The intervention group gets 1 practice test per eye. Then both groups get a regular automated visual field.

Study Ends, patient gets seen by the patient.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Puente Alto
      • Santiago, Puente Alto, Chile
        • Recruiting
        • Hospital Sotero del Rio
        • Principal Investigator:
          • Eugenio A Maul, MD MPH
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Jimena Schmidt, MD
        • Sub-Investigator:
          • Andres Gerhard, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years old or greater
  • Referred to the glaucoma clinic for examination due to suspected glaucoma or glaucoma diagnosis
  • No more than 1 automated visual field test within the last 4 years

Exclusion Criteria:

  • patients who cannot remain seated for 10 minutes
  • patients with neck problems that prevent them from using the field analyzer properly

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
No practice tests are performed in this arm
Experimental: Practice Program

At the 3 study visits exposed to a training session (simulated visual field test on a computer).

Visit 1 they get 2 simulated tests tests per eye. At visits 2 and 3 they get 1 simulated test per eye. Each simulated test takes 3-15 minutes

Each practice session (simulated visual field test on computer) takes 3-15 minutes
Other Names:
  • Computer Simulated practice Visual Field Test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The absolute value of the difference in mean deviation of the first and second visual field exam
Time Frame: Visual field exams obtained 1 to 2 weeks apart
Visual field exams obtained 1 to 2 weeks apart

Secondary Outcome Measures

Outcome Measure
Time Frame
Difference in the absolute number of altered points in the visual field with a total deviation below the 0.5 percentile
Time Frame: Visual field exams obtained 1 to 2 weeks apart
Visual field exams obtained 1 to 2 weeks apart
Difference in the percentage of false positives, false negatives, and fixation losses at the first and second exam between control and intervention group
Time Frame: Visual field exams obtained 1 to 2 weeks apart
Visual field exams obtained 1 to 2 weeks apart
Difference in the time required to complete the first and second exam
Time Frame: Visual field exams obtained 1 to 2 weeks apart
Visual field exams obtained 1 to 2 weeks apart
Difference in the proportion of unreliable visual fields at the first and second exam between control and intervention groups
Time Frame: Visual field exams obtained 1 to 2 weeks apart
Visual field exams obtained 1 to 2 weeks apart

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Anticipated)

May 1, 2013

Study Completion (Anticipated)

May 1, 2013

Study Registration Dates

First Submitted

August 16, 2012

First Submitted That Met QC Criteria

August 16, 2012

First Posted (Estimate)

August 20, 2012

Study Record Updates

Last Update Posted (Estimate)

August 20, 2012

Last Update Submitted That Met QC Criteria

August 16, 2012

Last Verified

August 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glaucoma

Clinical Trials on Practice program

3
Subscribe